🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchEcnoglutide, mazdutide, and other emerging GLP-1 pipeline agents Page 2

Ecnoglutide, mazdutide, and other emerging GLP-1 pipeline agents

TrialTracker_MD Thu, Jun 4, 2026 at 9:47 AM 19 replies 418 viewsPage 2 of 4
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Jun 4, 2026 at 12:29 PM#6

One concrete data point for the thread. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

6 9DadBodDave, AmyNC_wife, SkepticalSean and 3 others
Reply Quote Save Share Report
steph_laguna
Member
234
1,123
Nov 2024
Laguna Beach, CA
Jun 4, 2026 at 1:32 PM#7

One thing that is still open after Dr.MetabolicMD’s answer:

Did your prescriber agree with that reading, and if not what was their objection?

7 10GraceAZ_72, carl_compliance, DanielChem_CHI and 4 others
Reply Quote Save Share Report
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Jun 4, 2026 at 2:35 PM#8
dan_philly said:
One practical note: write down what you did and when, before you need it.

Coming at dan_philly’s question from a different direction. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Happy to go further on any of that.

8 11A1cHero_PHX, Dr.RenalNash, LipidDoc_ATL and 5 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jun 4, 2026 at 3:38 PM#9

Reporting back.

Closing the loop. The answer turned out to depend on the detail I had left out of the opening post, which is a lesson about how to ask rather than about the subject.

9 12Dr.PulmRoch, maya_sedona, stefan_berlin and 6 others
Reply Quote Save Share Report
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Jun 4, 2026 at 8:39 PM#10
Dr.DermMIA said:
If two explanations both fit, the useful question is which one predicts something the other does not.

No disagreement with Dr.DermMIA. One condition attached. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

Ask again with the specifics and you will get a better answer than this one.

33 8BethLabQueen, ChrisMacros, KetoKyle and 30 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register